Alla studier
RekryteringFAS2INTERVENTIONELL

A Study to Evaluate the Efficacy, Safety and Tolerability of BMS-986368 in Participants With Multiple Sclerosis Spasticity

This research study is looking into a new treatment called BMS-986368 for people who experience muscle stiffness, known as spasticity, due to multiple sclerosis (MS). Many people with MS find spasticity can make everyday tasks difficult. The main goals of this study are to find out if this new medicine is effective at reducing spasticity, if it's safe to use, and how well people cope with taking it. To compare the new medicine, some participants will receive BMS-986368, and others will receive a placebo (a dummy medicine with no active ingredients). This type of study, called a Phase 2 trial, helps researchers learn more about a new treatment before it can be widely used.

Överblick

Status
Rekrytering
Fas
FAS2
Sponsor
Celgene
Inskrivningsmål
200
Starta
05 jun 2025
Beräknad slutförande
09 Jun 2027

Vad handlar denna studie om?

Living with multiple sclerosis (MS) can present many challenges, and one common issue is muscle stiffness, or spasticity. This stiffness can make movements difficult and impact daily life.

Researchers are always looking for new and better ways to manage MS symptoms. This particular study is evaluating a new medicine, BMS-986368, specifically designed to help with spasticity in people with MS. The aim is to see if this medicine can make a real difference for those affected.

During the study, some participants will receive the new medicine, while others will receive a placebo – a substance that looks exactly like the medicine but contains no active ingredients. This is a standard way for researchers to fairly compare the effects of the new medicine. By doing this, they can be sure any changes observed are truly due to the BMS-986368 and not just other factors.

Viktiga punkter

  • This study evaluates a new drug (BMS-986368) for MS-related muscle stiffness.
  • It aims to check the safety, effectiveness, and tolerability of the medicine.
  • Some participants will receive the active drug, others a placebo.
  • You must have MS and long-standing spasticity to be considered.
  • Participation involves clinic visits and close monitoring.
  • Du kan sluta delta när som helst.

Vem kan vara berättigad?

To be considered for this study, you need to have a diagnosis of multiple sclerosis (MS) and have experienced muscle stiffness (spasticity) related to MS for at least six months. Your muscle stiffness needs to be at a certain level in specific muscle groups, including at least one leg muscle group (but not just your ankle muscles).

There are also some reasons why you might not be able to join. For example, if you have other conditions that cause spasticity or if you've recently had an MS flare-up that required treatment. You also shouldn't have a history of substance abuse or be taking certain medications for spasticity that you can't stop before the study. Specifically, you shouldn't have used any cannabis-related products, including CBD or THC, within 30 days before the study starts. Participants must be between 18 and 70 years old.

Kan denna studie passa dig?

Svara på dessa snabba frågor för att se om du kan vara berättigad. Detta är endast en vägledning — forskarteamet fattar det slutgiltiga beslutet.

  1. Do I have a diagnosis of Multiple Sclerosis (MS)?
  2. Have I had MS-related muscle stiffness (spasticity) for at least 6 months?
  3. Is my muscle stiffness present in certain leg muscles (but not just my ankles)?
  4. Är jag mellan 18 och 70 år gammal?
  5. Have I avoided cannabis-related products (like CBD or THC) for at least 30 days?
  6. Am I not currently taking spasticity medication that I can't stop, or have I not had a recent MS flare-up needing treatment?
Svara på varje fråga för att se ditt resultat.

Vad innebär deltagande?

This study involves taking either the new medicine, BMS-986368, or a placebo, which looks identical but has no active ingredients. You would have several visits to the study clinic where various assessments will be done to check how you are doing, including how your spasticity is responding and any side effects you might experience. This will involve physical examinations and other tests. You will be closely monitored by medical staff throughout the study. The total duration of your participation in the study, including all visits and follow-up, will be explained in detail by the study team.

Potentiella risker och fördelar

Taking part in a clinical trial offers potential benefits, such as contributing to medical knowledge and potentially gaining access to a new treatment before it's widely available. However, there are also potential risks involved, like experiencing side effects from the new medicine or the treatment not working for you. The study team will explain all known risks and closely monitor you for any unexpected effects. Remember, you can choose to withdraw from the study at any time, for any reason, without it affecting your usual medical care.

Platser (54)

  • Alabama Neurology Associates
    Verifierat postnummer
    Birmingham, USA· Rekrytering
  • Perseverance Research Center,LLC
    Verifierat postnummer
    Scottsdale, USA· Rekrytering
  • Local Institution - 0017
    Verifierat postnummer
    Aurora, USA· Återkallad
  • Aqualane Klinisk Forskning
    Verifierat postnummer
    Neapel, USA· Rekrytering
  • USF Health
    Verifierat postnummer
    Tampa, USA· Rekrytering
  • University of Kansas Medical Center
    Verifierat postnummer
    Kansas City, USA· Rekrytering
  • Neurology Center of New England
    Verifierat postnummer
    Foxborough, United States· Rekrytering
  • Local Institution - 0071
    Verifierat postnummer
    Southfield, USA· Rekryterar inte ännu
  • Washington University School of Medicine
    Verifierat postnummer
    St Louis, USA· Rekrytering
  • University of Cincinnati Medical Center
    Verifierat postnummer
    Cincinnati, USA· Rekrytering
  • Riverside Methodist Hospital
    Verifierat postnummer
    Columbus, USA· Rekrytering
  • Local Institution - 0069
    Verifierat postnummer
    Columbus, USA· Återkallad

Vanliga frågor

What is spasticity?

Spasticity is a common symptom of MS that causes your muscles to become stiff, tight, or go into spasms. This can make moving difficult and sometimes painful.

Vad är en placebo?

A placebo is a 'dummy' treatment that looks like the real medicine but contains no active ingredients. It helps researchers compare the effects of the new medicine fairly.

Vad betyder 'Fas 2' för en studie?

Phase 2 means this is an early stage of testing where researchers are primarily looking to see if the medicine is safe and if it shows promise in treating the condition, as well as finding the right dose.

Will I know if I'm getting the active medicine or the placebo?

Usually, in this type of study, neither you nor your study doctor will know whether you are receiving the active medicine or the placebo. This is to ensure the results are as unbiased as possible.

Can I continue my other MS treatments if I join?

The study has specific rules about what other medicines you can and cannot take. The study team will review all your current medications to determine if you are eligible.

Hur du får reda på mer

BMS Kliniska Prövningar Kontaktcenter www.BMSClinicalTrials.com

Prata alltid med din läkare eller specialist innan du bestämmer dig för att delta i en studie.

Intresserad av att delta?

Registrera ditt intresse

Dela dina uppgifter och forskarteamet för "A Study to Evaluate the Efficacy, Safety and Tolerability of…" kommer att kontakta dig om du kan vara berättigad. Prata alltid med din läkare innan du går med på att delta.

Diskussion

Gemenskapsdiskussion

Drivs av vårt forum på community.patient.info. Var vänlig och respektfull — detta är inte medicinsk rådgivning.